Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin A Nephropathy
PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Feb 16, 2024--
Source: eagletribune.com
Biological Licensing Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biological Licensing Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biological Licensing Application Today - Breaking & Trending Today
Sibeprenlimab Receives U.S. FDA Breakthrough Therapy Designation for the Treatment of Immunoglobulin
PRINCETON, N.J. & TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC); Otsuka Pharmaceutical, Co. Ltd. (Otsuka); and Visterra, Inc., an Otsuka group company announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designat...
Source: pharmiweb.com
Mirror Biologics, Inc. Announces Appointment of Brian Cregger as Vice President of Engineering Research and Development
Mirror Biologics, Inc., a clinical stage biopharmaceutical company, today announced that Brian Cregger was appointed as Vice President of Engineering...
Source: pr.com
Mirror Biologics, Inc. Announces Appointment of Yi Chen as Executive Vice President of Corporate Strategy and Planning
Mirror Biologics, Inc., a clinical stage biopharmaceutical company, today announced that Yi Shen, MBA was appointed as as Executive Vice President of...
Source: pr.com
Mirror Biologics, Inc. Appoints Carter J. Ward as Chief Financial Officer
Mirror Biologics, Inc. (“Mirror”), a clinical stage biopharmaceutical company today announced the appointment of Carter J. Ward as Chief...
Source: pr.com